Abstract
Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jaci.2023.11.043
Copy DOIPublication Date: Feb 1, 2024 |
Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study
Join us for a 30 min session where you can share your feedback and ask us any queries you have